Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2026-04-13 Regulatory Filings
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Sale or disposal
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board Meeting. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, which pertains to disclosure of material events by listed companies. The content details the Board's approval for closure/winding-up of a wholly owned subsidiary due to changed regulatory requirements and lack of business operations. The document includes an annexure with disclosures as per the regulation. There are no financial statements or detailed financial analysis present, and the document is relatively short (3418 characters). This is a regulatory announcement about a corporate action decided by the Board, not a full management report or financial report. It is not a report publication announcement since it contains substantive disclosure. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-13 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, which pertains to disclosure of material events by listed companies. The content informs about the Board's approval to close/wind-up a wholly owned subsidiary due to changed regulatory requirements and non-viability of business objectives. It includes a detailed disclosure as per regulatory requirements but does not contain financial statements or detailed financial analysis. The document is short (3418 characters) and serves as an official announcement of a corporate action decided by the Board, not a full report or financial filing. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about a corporate event without substantive financial data or report content.
2026-04-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming no requests for dematerialisation/rematerialisation of shares for the quarter ended March 31, 2026. It is a compliance certificate from the Registrar and Share Transfer Agent addressed to stock exchanges. The document length is short (2081 characters) and it primarily serves as a regulatory compliance attestation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate under a specific regulation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2026-04-06 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release dated March 18, 2026, announcing that Mankind Pharma has acquired the Rivotril brand for India. It details the acquisition, strategic focus, and company background. There are no financial statements, regulatory certifications, or detailed financial data. The document is an announcement of a corporate transaction (acquisition of a brand) but not a merger or takeover bid filing. It is not a full financial report, earnings release, or management discussion. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through acquisition of a brand. The document length is 5722 characters, sufficient for a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2026-03-18 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the increase in paid-up share capital, and references compliance with SEBI regulations related to share-based employee benefits. The document includes specifics such as share certificate numbers, ISIN, exercise price, and premium per share. This is a clear announcement of a share allotment event under an ESOP plan, which corresponds to a capital change event. It is not a full financial report, audit, or earnings release, nor is it a voting result or management change. The document is not a report publication announcement or a regulatory filing in the fallback sense, but a direct announcement of a capital change. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is under 5,000 characters but contains substantive details about the share allotment, so it is not merely an announcement of a report but the announcement of the capital change itself.
2026-03-16 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It informs about a regulatory order received by the company related to a tax penalty being dropped. The document references a previous intimation and provides details as per regulatory requirements. It is a disclosure of a material event to stock exchanges, not a full financial report or audit. The document length is short (3287 characters) and it serves as an announcement of a regulatory event rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-02-26 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.